Remington-Davis Enters Strategic Partnership With Assured Clinical Research

Remington-Davis, a leading clinical trial facility in Columbus, Ohio, is proud to announce a new strategic partnership with U.K.-based Assured Clinical Research, marking Assured’s first U.S. site collaboration.

Assured Clinical Research is building a next-generation clinical trial platform focused on disciplined growth, scalable access to patients, and close alignment with investigators and site leadership. With operations across the U.S. and U.K., their model is designed to streamline site engagement and enhance trial efficiency without sacrificing quality or the patient experience.

“Assured brings the kind of partnership that amplifies what we do best,” said RDI President Hamish Baird. “Their approach is collaborative, thoughtful, and focused on what matters, helping sites grow while delivering exceptional results for sponsors and patients alike.”

Founded in 1992, Remington-Davis has earned a reputation for excellence in Phase I–IV clinical trial execution. With over 600 successful trials completed across a range of therapeutic areas, they are known for operational agility, experienced staff, and deep commitment to patients. RDI’s culture is one based on quality, integrity, and continuous learning.

That foundation made RDI a natural fit for Assured’s site-first model, bringing together aligned teams to expand access, elevate trial delivery, and promote long-term site success.

“We see this as an opportunity to expand our impact while staying true to our core values,” Baird added. “Together with Assured, we look forward to accelerating access to innovative therapies and contributing to what’s next in clinical research.”

To learn more about this partnership, contact RDI.